TNF and Arthritis: Higher cardiovascular risk in patients with PsA can also be attributed to the combination of skin and joint inflammation, releasing higher amounts of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-17 and IL-23 [34].